The abridged South African hypertension guideline 2011

dc.contributor.authorSeedat, Y K
dc.contributor.authorRayner, B L
dc.date.accessioned2016-04-23T12:17:18Z
dc.date.available2016-04-23T12:17:18Z
dc.date.issued2013
dc.date.updated2016-04-21T08:50:59Z
dc.description.abstractExtensive data from randomised controlled trials have shown the benefit of treating hypertension. The target blood pressure (BP) for antihypertensive management is < 140/90 mmHg, and < 130/80 mmHg in patients with end-organ damage, coexisting risk factors, and co-morbidity. Benefits of management include reduced risk of death, stroke, cardiac failure, chronic kidney disease, and coronary heart disease. The correct BP measurement procedure is described, and evaluation of cardiovascular risk factors and recommendations for antihypertensive therapy, are stipulated. Lifestyle modification and patient education are cornerstones in the management of every patient. Major indications, precautions, and contraindications to each recommended antihypertensive drug are listed. Combination therapy should be considered ab initio if the BP is ≥ 20/10 mmHg above goal. First-line drug therapy for uncomplicated essential hypertension includes low-dose thiazide-like diuretics, calcium-channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers. The guideline was developed by the Southern African Hypertension Society.en_ZA
dc.identifierhttp://dx.doi.org/10.1080/20786204.2013.10874319
dc.identifier.apacitationSeedat, Y. K., & Rayner, B. L. (2013). The abridged South African hypertension guideline 2011. <i>South African Family Practice</i>, http://hdl.handle.net/11427/19151en_ZA
dc.identifier.chicagocitationSeedat, Y K, and B L Rayner "The abridged South African hypertension guideline 2011." <i>South African Family Practice</i> (2013) http://hdl.handle.net/11427/19151en_ZA
dc.identifier.citationSeedat, Y. K., & Rayner, B. L. (2013). The abridged South African hypertension guideline 2011. South African Family Practice, 55(2), 111-116.en_ZA
dc.identifier.issn2078-6190en_ZA
dc.identifier.ris TY - Journal Article AU - Seedat, Y K AU - Rayner, B L AB - Extensive data from randomised controlled trials have shown the benefit of treating hypertension. The target blood pressure (BP) for antihypertensive management is < 140/90 mmHg, and < 130/80 mmHg in patients with end-organ damage, coexisting risk factors, and co-morbidity. Benefits of management include reduced risk of death, stroke, cardiac failure, chronic kidney disease, and coronary heart disease. The correct BP measurement procedure is described, and evaluation of cardiovascular risk factors and recommendations for antihypertensive therapy, are stipulated. Lifestyle modification and patient education are cornerstones in the management of every patient. Major indications, precautions, and contraindications to each recommended antihypertensive drug are listed. Combination therapy should be considered ab initio if the BP is ≥ 20/10 mmHg above goal. First-line drug therapy for uncomplicated essential hypertension includes low-dose thiazide-like diuretics, calcium-channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin-receptor blockers. The guideline was developed by the Southern African Hypertension Society. DA - 2013 DB - OpenUCT DP - University of Cape Town J1 - South African Family Practice LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 SM - 2078-6190 T1 - The abridged South African hypertension guideline 2011 TI - The abridged South African hypertension guideline 2011 UR - http://hdl.handle.net/11427/19151 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/19151
dc.identifier.urihttp://www.tandfonline.com/doi/abs/10.1080/20786204.2013.10874319
dc.identifier.vancouvercitationSeedat YK, Rayner BL. The abridged South African hypertension guideline 2011. South African Family Practice. 2013; http://hdl.handle.net/11427/19151.en_ZA
dc.languageengen_ZA
dc.publisherSouth African Academy of Family Physiciansen_ZA
dc.publisher.departmentDepartment of Medicineen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rightsCreative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/za/en_ZA
dc.sourceSouth African Family Practiceen_ZA
dc.source.urihttp://www.safpj.co.za/index.php/safpj
dc.subject.otherabridged
dc.subject.otherSouth African hypertension guideline
dc.subject.other2011
dc.titleThe abridged South African hypertension guideline 2011en_ZA
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Seedat_abridged_South_African_2013.pdf
Size:
317.39 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections